Max Healthcare to file NCLT reply in BRS Capital petition

0 min read | Published on 11 Sept 2026, 05:15 PM |Updated on 11 Sept 2026, 05:15 PM

Reviewed by

Anirudha BScanX News Team

Add as a preferred
source on Google

Key Highlights

NCLT directs Max Healthcare to file reply within one week
Case involves BRS Capital petitions against subsidiary Kalinga Hospital
Next hearing scheduled for September 28, 2026
Disclosure made under SEBI Regulation 30 on September 11

*this image is generated using AI for illustrative purposes only.

The National Company Law Tribunal has directed Max Healthcare Institute to file its reply within one week regarding ongoing litigation involving its subsidiary, Kalinga Hospital Ltd.

The Cuttack Bench of the NCLT heard the matter on September 8, 2026. The proceedings involve interlocutory petitions filed by the legal representatives of BRS Capital Two Pte. Limited against Kalinga Hospital and Max Healthcare.

Litigation Background

This disclosure follows an earlier intimation dated August 19, 2026. BRS Capital, the other shareholder from whom Max Healthcare acquired the majority equity stake in Kalinga Hospital, filed the petitions. The legal representatives sought certain interim reliefs through additional interlocutory applications.

Procedural Timeline

Event	Date
Petition hearing	September 8, 2026
Order received by company	September 10, 2026
Reply filing deadline	One week from order
Next hearing date	September 28, 2026

Max Healthcare received the copy of the NCLT order on September 10, 2026, at 4:42 pm. The company disclosed this development under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Max Healthcare Institute

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.09%	+4.30%	-2.93%	-0.52%	-12.11%	0.0%

How might the outcome of the BRS Capital litigation impact Max Healthcare's future expansion plans in the eastern India market?

Could the interim reliefs sought by BRS Capital lead to operational disruptions or governance changes at Kalinga Hospital?

What are the potential financial implications for Max Healthcare if the NCLT rules in favor of the petitioners regarding equity stakes?

Max Healthcare Institute

View Company Insights

View All News

Max Healthcare raises stake in Kalinga Hospital to 66.15% after ₹87.87 Cr infusion

1 min read | Published on 03 Sept 2026, 04:00 PM |Updated on 08 Sept 2026, 03:48 AM

Reviewed by

Shriram SScanX News Team

Add as a preferred
source on Google

Key Highlights

Max Healthcare increased its stake in Kalinga Hospital Ltd to ~66.15% from ~58.28%
The company completed a ₹87.87 crore rights share subscription on September 7, 2026
Allotment of 50,21,212 equity shares was confirmed by the subsidiary
Kalinga Hospital reported revenue of ~₹155.64 crore in FY 2025-26

*this image is generated using AI for illustrative purposes only.

Max Healthcare Institute confirmed the completion of its ₹87.87 crore rights share subscription in subsidiary Kalinga Hospital Ltd on September 7, 2026. The allotment of 50,21,212 equity shares increased the company’s holding in the entity from ~58.28% to ~66.15%.

The transaction follows the approval by the Renewable Energy and Subsidiary Investment Committee on September 3, 2026. The committee authorized the capital infusion to support clinical modernization and optimize the subsidiary’s capital structure.

Transaction Completion

Max Healthcare received communication from Kalinga Hospital Ltd confirming the allotment at 5:13 pm on September 7, 2026. The investment was executed through a cash consideration instrument on a rights basis. No governmental or regulatory approvals were required for this related-party transaction, as it is exempt under SEBI listing regulations due to Kalinga Hospital being a wholly owned subsidiary prior to the stake increase.

Particulars	Details
Target Entity	Kalinga Hospital Ltd
Infusion Amount	~₹87.87 crore
Instrument	Rights share subscription
Shares Allotted	50,21,212 equity shares
Stake Increase	From ~58.28% to ~66.15%
Completion Date	September 7, 2026

Subsidiary Profile

Kalinga Hospital Ltd operates in the healthcare services sector with a paid-up capital of ₹21.54 crore. The subsidiary reported revenue from operations of ~₹155.64 crore during FY 2025-26. The proposed investment addresses general corporate requirements alongside specific capital expenditure needs for operational expansion.

Historical Stock Returns for Max Healthcare Institute

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.09%	+4.30%	-2.93%	-0.52%	-12.11%	0.0%

How will the increased 66.15% stake in Kalinga Hospital impact Max Healthcare's consolidated earnings and EBITDA margins in the upcoming fiscal quarters?

What specific clinical modernization projects or infrastructure upgrades is Kalinga Hospital prioritizing with the ₹87.87 crore capital infusion?

Does this deeper consolidation signal Max Healthcare's broader strategy to acquire or increase stakes in regional healthcare providers to expand its geographic footprint?

Max Healthcare Institute

View Company Insights

View All News